Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)

LCTX

AMX
Lineage Cell Therapeutics, Inc.
ManufacturingBiological Product (except Diagnostic) Manufacturing
Watchlist:
Last updated: Monday 7th July 2025
1.01
-0.01 (-0.98%)
Prev Close:1.02
Open:1.04
Bid:1.01
Ask:1.02
52 Week Range
0.37
1.15
Volume:2,129,131
Mkt Cap:205 M
Price Target
$1.16
+14.9%
Financials

Financial Statements

LCTX - Cash Flow (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-14
Asset Impairment Charge9000.0
Capital Expenditure Reported565000.0413000.0340000.064000.0440000.01 M1 M3 M702000.0
Cash Flow From Continuing Investing Activities-2 M46 M-46 M10 M13 M17 M-10 M-1 M-3 M-1 M
Change In Account Payable-2 M-2 M-19 M22 M308000.0-3 M1 M1 M12000.0-470000.0
Change In Payables And Accrued Expense-2 M-2 M-19 M22 M308000.0-3 M1 M1 M12000.0-470000.0
Change In Prepaid Assets489000.0-418000.0446000.0-72000.02 M-260000.0-437000.0145000.0-1 M-86000.0
Change In Working Capital-9 M-11 M19 M21 M1 M-2 M621000.02 M-972000.0-903000.0
Changes In Account Receivables106000.0-446000.050 M-857000.0287000.0467000.046000.0-172000.0187000.0-74000.0
Common Stock Payments-106000.0-1 M-356000.0
Depreciation And Amortization609000.0692000.0682000.0873000.02 M3 M3 M4 M5 M9 M
Earnings Losses From Equity Investments8000.0176000.02 M-3 M5 M
Financing Cash Flow36 M6 M2 M37 M30 M617000.06 M55 M33 M64 M
Gain Loss On Investment Securities-5 M-3 M-1 M
Gain Loss On Sale Of PPE-11000.024000.0-20000.0273000.0-105000.0-2 M
Interest Paid Supplemental Data13000.013000.020000.028000.0155000.0156000.094000.091000.0
Issuance Of Capital Stock148000.031 M5 M103000.049 M20 M44 M
Issuance Of Debt-54000.0-32000.025 M-70000.0-101000.0172000.02 M471000.0
Net Business Purchase And Sale3 M-8 M-4 M
Net Common Stock Issuance42000.030 M5 M103000.049 M20 M44 M
Net Foreign Currency Exchange Gain Loss602000.02 M
Net Investment Properties Purchase And Sale-2 M-16 M-46 M10 M13 M14 M-8000.0-201000.013000.0-315000.0
Net Investment Purchase And Sale-2 M-16 M-46 M10 M13 M14 M-8000.0-201000.013000.0-315000.0
Net Issuance Payments Of Debt-54000.0-32000.025 M-70000.0-101000.0172000.02 M471000.0
Net Long Term Debt Issuance-54000.0-32000.025 M-70000.0-101000.0172000.02 M471000.0
Net PPE Purchase And Sale-565000.0-413000.0-340000.0-41000.0-358000.0-1 M-1 M-3 M-693000.0
Net Preferred Stock Issuance4 M
Other Non-cash Items4 M5 M4 M-2 M-889000.0-11 M-66 M3 M13 M5 M
Preferred Stock Issuance4 M
Proceeds From Issuance Of Warrants991000.050.0
Proceeds From Stock Option Exercised229000.0648000.07 M25000.02 M227000.0
Purchase Of Investment-9 M-16 M-53 M-189000.0
Purchase Of PPE-565000.0-413000.0-340000.0-64000.0-440000.0-1 M-1 M-3 M-702000.0
Repayment Of Debt-54000.0-32000.0-70000.0-101000.0-253000.0-145000.0
Sale Of Business-6 M-4 M
Sale Of Investment7 M196000.08 M10 M13 M14 M
Sale Of PPE14000.023000.082000.0200000.09000.0
Stock Based Compensation5 M5 M4 M4 M2 M4 M5 M4 M8 M4 M
Unrealized Gain Loss On Investment Securities-2 M-2000.0-225000.0-15 M
Amord22000.0130000.0100000.0210000.01 M2 M2 M2 M4 M8 M
Begcash56 M33 M10 M24 M38 M23 M42 M5 M
Capex-565000.0-413000.0-340000.0-41000.0-358000.0-1 M-1 M-3 M-693000.0
Cffcf36 M6 M2 M37 M30 M617000.06 M55 M33 M64 M
Cffinv-2 M46 M-46 M10 M13 M17 M12 M-10 M-3 M-1 M
Cffoa-23 M-29 M1 M-24 M-20 M-32 M-109 M-6 M41 M-39 M
Chgcash10 M24 M-43 M23 M23 M-14 M-13 M15 M71 M24 M
Chginv-87000.0
Chgothca-487000.0-22000.0-56000.0
Chgothcl-8 M-8 M-13 M380000.0-143000.016000.076000.0-186000.0
Chgothwc-49 M
Chgpay-2 M-2 M-19 M22 M308000.0-3 M1 M1 M12000.0-470000.0
Chgrec106000.0-446000.050 M-857000.0-714000.01 M101000.0985000.0187000.0-74000.0
Comstkiss148000.031 M5 M103000.049 M20 M44 M
Definc-2 M-1 M-7 M
Deftax-2 M-1 M-7 M
Depamor587000.0562000.0682000.0663000.02 M3 M3 M4 M5 M9 M
Effexch-95000.0-873000.0-20000.0-63000.070000.06000.0101000.0292000.0230000.0
Endcash46 M-45 M12 M56 M33 M10 M24 M37 M114 M29 M
Fcf-24 M-29 M646000.0-24 M-20 M-32 M-32 M-32 M38 M-40 M
Ltdebtiss25 M425000.02 M471000.0
Ltdebtpay-54000.0-32000.0-70000.0-101000.0-253000.0-145000.0
Netinccont-19 M-21 M-26 M-43 M-21 M-12 M-45 M-17 M19 M-44 M
Netothfin-194000.0-17000.0-74000.025 M584000.06 M6 M9 M15 M
Netothinv18000.0-17000.0-8000.0-12000.013000.0-315000.0
Opcf-23 M-29 M1 M-24 M-20 M-32 M-31 M-31 M41 M-39 M
Opgainloss8000.0176000.04 M-499000.0-20000.0-3 M-1 M1 M5 M
Purchbus3 M-2 M
Purchsti-9 M-16 M-53 M-189000.0
Repurchstk-106000.0-1 M-356000.0
Salelti8 M10 M13 M14 M
Salesti7 M196000.08 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader